Alzamend Neuro Inc (ALZN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.8M |
| Enterprise Value | 3.09M |
| P/E Ratio | -0.53 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.94 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.19 |
Fiscal Year
| Fiscal Year | April 30, 2026 |
| Most Recent Quarter | July 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.06 |
| Return On Equity | -2.78 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -8.66M |
| Net Income | -8.77M |
| Diluted EPS | -2.63 |
Balance Sheet
| Total Cash | 7.59M |
| Total Cash/Share | 1.7 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.01 |
| Book Value Per Share | 1.3 |
Price History
| 52-Week Change | -47.84 |
| 52-Week High | 8.22 |
| 52-Week Low | 0.84 |
| Moving Average 50 Days | 1.59 |
| Moving Average 200 Days | 1.52 |
Statistics
| Average Volume | 80,990 |
| Shares Outstanding | 4.83M |
| % Held by Institutions | 17.93 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | May 12, 2025 |
AD
